Professor Andrew Morris

ANDREW MORRIS is the Professor of Diabetic Medicine and Director of the Biomedical Research Institute at the University of Dundee. His research interests focuses on the application of informatics to study the epidemiological and molecular aetiological basis of diabetes and its complications. He also has a major interest in how managed clinical networks can improve patient care across geographical boundaries. He leads the DARTS research study, has published over 180 original papers and has attracted over £20million in peer reviewed grant funding. He is the principal investigator on many clinical studies of new therapeutics of diabetes as well as genetics of diabetes, including the Wellcome Trust United Kingdom Case Control Collection for Type 2 Diabetes that is recruiting 15,000 individuals. He is also the principal investigator of Generation Scotland, a study of the genetic health in 50,000 Scots. He was awarded the RD Lawrence Award by Diabetes UK in 2003, the Saltire Society Scottish Science Award in 2005 and is a Fellow of the Royal Society of Edinburgh, Scotland’s national academy of science and letters. He was appointed by the Minister for Health and Community Care to be Lead Clinician for diabetes in Scotland (2002-2006) and led a national programme of quality improvement in diabetes care. He is also the eHealth Director of NHS Tayside and chairs the Translational Medicine Research Collaboration Steering Group, unique £50million collaboration between all Medical Schools in Scotland and the pharmaceutical giant Wyeth.

Fischbacher CM, Bhopal R, Steiner M, Morris AD, Chalmers J. Is there equity of service delivery and intermediate outcomes in South Asians with type 2 diabetes? Analysis of DARTS database and summary of UK publications. J Public Health (Oxf). 2009 31(2):239-49.

Macleod AK, Liewald DC, McGilchrist MM, Morris AD, Kerr SM, Porteous DJ. Some principles and practices of genetic biobanking studies. Eur Respir J. 2009 33(2):419-25.

Donnelly LA, Morris AD, Pearson ER. Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes Obes Metab. 2009 11(4):338-42.

Prokopenko I, Zeggini E, Hanson RL, Mitchell BD, Rayner NW, Akan P, Baier L, Das SK, Elliott KS, Fu M, Frayling TM, Groves CJ, Gwilliam R, Scott LJ, Voight BF, Hattersley AT, Hu C, Morris AD, Ng M, Palmer CN, Tello-Ruiz M, Vaxillaire M, Wang CR, Stein L, Chan J, Jia W, Froguel P, Elbein SC, Deloukas P, Bogardus C, Shuldiner AR, McCarthy MI; for the International Type 2 Diabetes 1q. Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q. Diabetes. 2009 58(7):1704-9.

Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN. A single nucleotide polymorphism on exon-4 of the gene encoding PPAR{delta} is associated with reduced height in adults and children. J Clin Endocrinol Metab. 2009 94(7):2587-93.